Description du projet
Améliorer la santé du bétail grâce à la technologie acoustique
La mammite bovine est une réaction inflammatoire et persistante du tissu de la mamelle causée par un traumatisme physique ou par des infections d’origine microbienne. Il s’agit de la maladie la plus répandue chez les vaches laitières à l’échelle mondiale. L’utilisation continue d’antibiotiques pour la traiter fragilise la santé des bovins, ce qui réduit la production laitière et affaiblit les vaches à tel point qu’on les retire du troupeau. Le projet APT, financé par l’UE, a mis au point des thérapies innovantes sans antibiotique et non invasives qui reposent sur la technologie des impulsions acoustiques. Cette méthode éprouvée est utilisée depuis plus de 20 ans en médecine humaine pour traiter les maladies inflammatoires. Le projet entend y avoir recours pour concevoir des solutions optimales pour la mammite bovine.
Objectif
"Armenta Ltd, was established to address the most-costly disease affecting dairy farming today: Bovine Mastitis.
Mastitis is the most pressing disease affecting cows, however antibiotics are the only available option worldwide - close to 50% of antibiotics are used in food producing animals. The continued use of antibiotics in the treatment and prevention of infections of dairy cows has a direct effect on fostering Anti-Microbial Resistance (AMR), an urgent matter of particular public interest. The continued use of antibiotics also weakens the cow’s health, decreasing its milk production and eventually, weak cows are removed from the herd, causing high economic losses that can reach €2.4B per year in Europe alone. Armenta was therefore established to address these pressing economic effects, with a revolutionary way of using APT.
Armenta developed innovative non-invasive; antibiotics free therapies based on acoustic pulse technology (APT). APT has been used for over 20 years in human healthcare treating inflammatory diseases. Armenta employs experts in acoustic pulse treatment and engineering, mastitis researchers, ex-dairy farmers and dairy farming operation, bringing their skills and proficiency into developing the optimal solutions for bovine mastitis.
Armenta aims at becoming a leader in 1) fighting the spread of AMR 2) boosting the dairy economy giving €1.4B cash back to the EU farmers each year 3) increasing cow’s welfare and longevity. Moreover, it aims at being considered the #1 alternative to antibiotics, endorsed by leading international organization.
"
Champ scientifique
- medical and health scienceshealth sciencesinflammatory diseases
- agricultural sciencesanimal and dairy sciencedairy
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- agricultural sciencesanimal and dairy sciencedomestic animalsanimal husbandry
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Programme(s)
Régime de financement
SME - SME instrumentCoordinateur
4427120 KFAR SAVA
Israël
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.